

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.65921907 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.10997093 |
| 3 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.10687995 |
| 4 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.10687995 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.02268759 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.02268759 |
| 7 | protein complex biogenesis (GO:0070271) | 3.98585769 |
| 8 | proteasome assembly (GO:0043248) | 3.83537338 |
| 9 | chaperone-mediated protein transport (GO:0072321) | 3.81578512 |
| 10 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.71489938 |
| 11 | protein-cofactor linkage (GO:0018065) | 3.71474018 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.64299242 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 3.64299242 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.64299242 |
| 15 | protein neddylation (GO:0045116) | 3.57567316 |
| 16 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.54557865 |
| 17 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.52544149 |
| 18 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.49518039 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.49293206 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.41653212 |
| 21 | cytidine metabolic process (GO:0046087) | 3.40540744 |
| 22 | cytidine catabolic process (GO:0006216) | 3.40540744 |
| 23 | cytidine deamination (GO:0009972) | 3.40540744 |
| 24 | respiratory electron transport chain (GO:0022904) | 3.38891484 |
| 25 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.37942710 |
| 26 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.36987666 |
| 27 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.36987666 |
| 28 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.36987666 |
| 29 | platelet dense granule organization (GO:0060155) | 3.36836492 |
| 30 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.36265038 |
| 31 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.36265038 |
| 32 | electron transport chain (GO:0022900) | 3.36151280 |
| 33 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.35813779 |
| 34 | iron-sulfur cluster assembly (GO:0016226) | 3.25952165 |
| 35 | metallo-sulfur cluster assembly (GO:0031163) | 3.25952165 |
| 36 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.24143527 |
| 37 | ribosomal small subunit assembly (GO:0000028) | 3.22224759 |
| 38 | respiratory chain complex IV assembly (GO:0008535) | 3.19233942 |
| 39 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.18375632 |
| 40 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.18375632 |
| 41 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.16490042 |
| 42 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10546987 |
| 43 | pseudouridine synthesis (GO:0001522) | 3.05258114 |
| 44 | negative regulation of ligase activity (GO:0051352) | 3.04096087 |
| 45 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.04096087 |
| 46 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.03788581 |
| 47 | cytochrome complex assembly (GO:0017004) | 3.00018926 |
| 48 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.99705358 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.97867631 |
| 50 | mannosylation (GO:0097502) | 2.94583733 |
| 51 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.93167415 |
| 52 | peptidyl-histidine modification (GO:0018202) | 2.90708333 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89644437 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.86139079 |
| 55 | positive regulation of ligase activity (GO:0051351) | 2.81324158 |
| 56 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.73946815 |
| 57 | protein deneddylation (GO:0000338) | 2.73013379 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71447862 |
| 59 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.68430444 |
| 60 | response to interferon-beta (GO:0035456) | 2.68370736 |
| 61 | DNA double-strand break processing (GO:0000729) | 2.67548621 |
| 62 | GDP-mannose metabolic process (GO:0019673) | 2.66815394 |
| 63 | negative regulation of telomere maintenance (GO:0032205) | 2.65578093 |
| 64 | base-excision repair, AP site formation (GO:0006285) | 2.64972345 |
| 65 | spliceosomal snRNP assembly (GO:0000387) | 2.64855821 |
| 66 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.62832635 |
| 67 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.62406543 |
| 68 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.60455240 |
| 69 | deoxyribonucleotide catabolic process (GO:0009264) | 2.58777133 |
| 70 | positive regulation of cell cycle arrest (GO:0071158) | 2.58550867 |
| 71 | protein K6-linked ubiquitination (GO:0085020) | 2.55362236 |
| 72 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.55235123 |
| 73 | cellular response to interferon-beta (GO:0035458) | 2.54434864 |
| 74 | resolution of meiotic recombination intermediates (GO:0000712) | 2.52626197 |
| 75 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.52349562 |
| 76 | cotranslational protein targeting to membrane (GO:0006613) | 2.51403901 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.50472698 |
| 78 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.50472698 |
| 79 | hydrogen ion transmembrane transport (GO:1902600) | 2.47889039 |
| 80 | regulation of cellular amine metabolic process (GO:0033238) | 2.47336823 |
| 81 | protein targeting to ER (GO:0045047) | 2.47053347 |
| 82 | translational termination (GO:0006415) | 2.46955214 |
| 83 | tRNA processing (GO:0008033) | 2.45599763 |
| 84 | viral transcription (GO:0019083) | 2.44894782 |
| 85 | cullin deneddylation (GO:0010388) | 2.44853924 |
| 86 | purine-containing compound salvage (GO:0043101) | 2.44572313 |
| 87 | dopamine transport (GO:0015872) | 2.43068359 |
| 88 | proton transport (GO:0015992) | 2.42498492 |
| 89 | GPI anchor metabolic process (GO:0006505) | 2.42493143 |
| 90 | ATP biosynthetic process (GO:0006754) | 2.40594881 |
| 91 | hydrogen transport (GO:0006818) | 2.40184147 |
| 92 | adaptation of signaling pathway (GO:0023058) | 2.38230552 |
| 93 | mitochondrial calcium ion transport (GO:0006851) | 2.38214759 |
| 94 | response to pheromone (GO:0019236) | 2.37554815 |
| 95 | deoxyribose phosphate catabolic process (GO:0046386) | 2.36507408 |
| 96 | GPI anchor biosynthetic process (GO:0006506) | 2.36464754 |
| 97 | anterograde synaptic vesicle transport (GO:0048490) | 2.36329309 |
| 98 | maturation of 5.8S rRNA (GO:0000460) | 2.36130057 |
| 99 | replication fork processing (GO:0031297) | 2.35337588 |
| 100 | rRNA modification (GO:0000154) | 2.35204468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.71754668 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.41011948 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.10803181 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.96140086 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.86042481 |
| 6 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.10194783 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.03985984 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.02023813 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.99655491 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.96426184 |
| 11 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.87010107 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.72596584 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60462890 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.57890450 |
| 15 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.48808388 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.41768379 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.36710512 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29660283 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28847903 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28249456 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.22412005 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.05363770 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05195761 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96495169 |
| 25 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.76798106 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76447595 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70957045 |
| 28 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70034057 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67147770 |
| 30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66473707 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65073555 |
| 32 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64634108 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.64401738 |
| 34 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.60884503 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58900332 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58737551 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58168497 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.57625546 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55585165 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.55225626 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53737828 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.50887730 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.50463286 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43223573 |
| 45 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.42072129 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41197409 |
| 47 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40978509 |
| 48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38215523 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36824801 |
| 50 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31179863 |
| 51 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.30837015 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30794723 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22226984 |
| 54 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19700611 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18765255 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18737176 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16969778 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15036225 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14888918 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14719686 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13861537 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12429835 |
| 63 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11318600 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08420006 |
| 65 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06964488 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06845036 |
| 67 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06603997 |
| 68 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05856264 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.05823155 |
| 70 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04711312 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03590627 |
| 72 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.03522261 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02243525 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02182634 |
| 75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00798545 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99782381 |
| 77 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99544649 |
| 78 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98129162 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97726952 |
| 80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.97707560 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.97707560 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96689210 |
| 83 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94855430 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94506601 |
| 85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.93579936 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93562493 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91312505 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87945487 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85488225 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85118295 |
| 91 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84971018 |
| 92 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84971018 |
| 93 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81631917 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81534790 |
| 95 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.81434415 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.80815303 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.80316730 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.80281849 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79864559 |
| 100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79472312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 3.34828989 |
| 2 | MP0005671_abnormal_response_to | 2.77246047 |
| 3 | MP0008877_abnormal_DNA_methylation | 2.49590084 |
| 4 | MP0002102_abnormal_ear_morphology | 2.41102868 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 2.20692128 |
| 6 | MP0008058_abnormal_DNA_repair | 2.15882527 |
| 7 | MP0008995_early_reproductive_senescence | 2.12085450 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.10113330 |
| 9 | MP0000372_irregular_coat_pigmentation | 2.08662500 |
| 10 | MP0009785_altered_susceptibility_to | 2.04434332 |
| 11 | MP0001835_abnormal_antigen_presentation | 1.92626320 |
| 12 | MP0006035_abnormal_mitochondrial_morpho | 1.90963526 |
| 13 | MP0001905_abnormal_dopamine_level | 1.84387435 |
| 14 | MP0006292_abnormal_olfactory_placode | 1.79152543 |
| 15 | MP0001529_abnormal_vocalization | 1.77151177 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 1.70970007 |
| 17 | MP0003786_premature_aging | 1.69083754 |
| 18 | MP0003718_maternal_effect | 1.68366459 |
| 19 | MP0004142_abnormal_muscle_tone | 1.66369037 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 1.63701167 |
| 21 | MP0003186_abnormal_redox_activity | 1.63363808 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.62717343 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.59831467 |
| 24 | MP0003011_delayed_dark_adaptation | 1.58010934 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.56878789 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.51283984 |
| 27 | MP0001800_abnormal_humoral_immune | 1.50240656 |
| 28 | MP0002736_abnormal_nociception_after | 1.45915123 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.45699614 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.41261241 |
| 31 | MP0002723_abnormal_immune_serum | 1.39927212 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.39359986 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.36544455 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.35512355 |
| 35 | MP0002132_abnormal_respiratory_system | 1.35080305 |
| 36 | MP0001764_abnormal_homeostasis | 1.34628757 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.31428667 |
| 38 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29497758 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.29299098 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.27220618 |
| 41 | MP0010094_abnormal_chromosome_stability | 1.26953373 |
| 42 | MP0000685_abnormal_immune_system | 1.26723454 |
| 43 | MP0001819_abnormal_immune_cell | 1.26544364 |
| 44 | MP0005025_abnormal_response_to | 1.26529807 |
| 45 | MP0008872_abnormal_physiological_respon | 1.26144868 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.22975240 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.21827091 |
| 48 | MP0005253_abnormal_eye_physiology | 1.21691376 |
| 49 | MP0001919_abnormal_reproductive_system | 1.21327815 |
| 50 | MP0003878_abnormal_ear_physiology | 1.19989187 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.19989187 |
| 52 | MP0005387_immune_system_phenotype | 1.18997088 |
| 53 | MP0001790_abnormal_immune_system | 1.18997088 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.18898342 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.17589333 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.14730660 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.12067870 |
| 58 | MP0005499_abnormal_olfactory_system | 1.12067870 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.11757210 |
| 60 | MP0009840_abnormal_foam_cell | 1.10266044 |
| 61 | MP0002398_abnormal_bone_marrow | 1.08797547 |
| 62 | MP0005389_reproductive_system_phenotype | 1.07650087 |
| 63 | MP0005310_abnormal_salivary_gland | 1.07364455 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.05214910 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.03870147 |
| 66 | MP0000716_abnormal_immune_system | 1.03591432 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.03173494 |
| 68 | MP0002006_tumorigenesis | 1.01184117 |
| 69 | MP0001929_abnormal_gametogenesis | 1.00602421 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.99511028 |
| 71 | MP0002722_abnormal_immune_system | 0.94912675 |
| 72 | MP0003763_abnormal_thymus_physiology | 0.94819650 |
| 73 | MP0009764_decreased_sensitivity_to | 0.94273813 |
| 74 | MP0001485_abnormal_pinna_reflex | 0.92757064 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.92234443 |
| 76 | MP0003136_yellow_coat_color | 0.91266377 |
| 77 | MP0002429_abnormal_blood_cell | 0.90809033 |
| 78 | MP0001845_abnormal_inflammatory_respons | 0.89627649 |
| 79 | MP0008469_abnormal_protein_level | 0.89328987 |
| 80 | MP0002405_respiratory_system_inflammati | 0.87758513 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 0.86804799 |
| 82 | MP0005332_abnormal_amino_acid | 0.85736829 |
| 83 | MP0003787_abnormal_imprinting | 0.85726321 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.83334496 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.82425387 |
| 86 | MP0002938_white_spotting | 0.82411531 |
| 87 | MP0002210_abnormal_sex_determination | 0.81041451 |
| 88 | MP0002163_abnormal_gland_morphology | 0.80890972 |
| 89 | MP0003195_calcinosis | 0.79675942 |
| 90 | MP0002735_abnormal_chemical_nociception | 0.79108729 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.79104903 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.79039340 |
| 93 | MP0004742_abnormal_vestibular_system | 0.78796733 |
| 94 | MP0003077_abnormal_cell_cycle | 0.77058370 |
| 95 | MP0002419_abnormal_innate_immunity | 0.76238922 |
| 96 | MP0005410_abnormal_fertilization | 0.75525546 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.75206930 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.75206930 |
| 99 | MP0001873_stomach_inflammation | 0.74936156 |
| 100 | MP0001984_abnormal_olfaction | 0.74297811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 3.96217981 |
| 2 | Mitochondrial inheritance (HP:0001427) | 3.87899038 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.76081853 |
| 4 | Acute encephalopathy (HP:0006846) | 3.66617072 |
| 5 | Increased CSF lactate (HP:0002490) | 3.63565935 |
| 6 | Hepatocellular necrosis (HP:0001404) | 3.47134308 |
| 7 | Hepatic necrosis (HP:0002605) | 3.31986091 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.29877019 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28481486 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.24186486 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13572189 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.06832114 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.04696193 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.96322238 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.92993038 |
| 16 | Increased serum lactate (HP:0002151) | 2.86827812 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.82221438 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.82221438 |
| 19 | Increased intramyocellular lipid droplets (HP:0012240) | 2.74867760 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 2.70354745 |
| 21 | Methylmalonic acidemia (HP:0002912) | 2.69308525 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68545889 |
| 23 | Aplastic anemia (HP:0001915) | 2.62713641 |
| 24 | Lactic acidosis (HP:0003128) | 2.62189269 |
| 25 | IgG deficiency (HP:0004315) | 2.59324069 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53297069 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.48958346 |
| 28 | Cerebral edema (HP:0002181) | 2.47280134 |
| 29 | Abnormality of B cell number (HP:0010975) | 2.45211541 |
| 30 | Congenital stationary night blindness (HP:0007642) | 2.43952541 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.43591690 |
| 32 | Methylmalonic aciduria (HP:0012120) | 2.40065659 |
| 33 | Exertional dyspnea (HP:0002875) | 2.39598754 |
| 34 | Pancreatic cysts (HP:0001737) | 2.38808670 |
| 35 | B lymphocytopenia (HP:0010976) | 2.36076855 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.34976801 |
| 37 | Medial flaring of the eyebrow (HP:0010747) | 2.28013198 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.27262905 |
| 39 | Optic disc pallor (HP:0000543) | 2.26101161 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 2.24991798 |
| 41 | Lethargy (HP:0001254) | 2.22636785 |
| 42 | Abnormality of midbrain morphology (HP:0002418) | 2.17398608 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 2.17398608 |
| 44 | Stomatitis (HP:0010280) | 2.15828401 |
| 45 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10668759 |
| 46 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10668759 |
| 47 | Abnormal protein glycosylation (HP:0012346) | 2.10668759 |
| 48 | Abnormal glycosylation (HP:0012345) | 2.10668759 |
| 49 | Exercise intolerance (HP:0003546) | 2.07810816 |
| 50 | Renal cortical cysts (HP:0000803) | 2.07753847 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07749849 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.07749849 |
| 53 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.05940503 |
| 54 | Abnormality of renal resorption (HP:0011038) | 2.05010738 |
| 55 | True hermaphroditism (HP:0010459) | 2.04892977 |
| 56 | Hyperglycinemia (HP:0002154) | 2.04247905 |
| 57 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02074466 |
| 58 | Pancreatic fibrosis (HP:0100732) | 2.02060555 |
| 59 | Respiratory failure (HP:0002878) | 1.99804241 |
| 60 | Increased IgM level (HP:0003496) | 1.98614055 |
| 61 | CNS demyelination (HP:0007305) | 1.98206763 |
| 62 | Hypoproteinemia (HP:0003075) | 1.97541445 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 1.97055119 |
| 64 | Optic neuritis (HP:0100653) | 1.97055119 |
| 65 | Encephalitis (HP:0002383) | 1.96665930 |
| 66 | Nausea (HP:0002018) | 1.95447684 |
| 67 | Type 2 muscle fiber atrophy (HP:0003554) | 1.94126967 |
| 68 | Pancytopenia (HP:0001876) | 1.93178821 |
| 69 | Severe visual impairment (HP:0001141) | 1.92235649 |
| 70 | Macrocytic anemia (HP:0001972) | 1.91718635 |
| 71 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91430902 |
| 72 | Congenital primary aphakia (HP:0007707) | 1.90940895 |
| 73 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90221269 |
| 74 | Nephronophthisis (HP:0000090) | 1.88907143 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 1.87942582 |
| 76 | Glycosuria (HP:0003076) | 1.87942582 |
| 77 | Gait imbalance (HP:0002141) | 1.83786842 |
| 78 | Reticulocytopenia (HP:0001896) | 1.83639923 |
| 79 | Abolished electroretinogram (ERG) (HP:0000550) | 1.83220065 |
| 80 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80943076 |
| 81 | Combined immunodeficiency (HP:0005387) | 1.80291355 |
| 82 | Thyroiditis (HP:0100646) | 1.80188324 |
| 83 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79906149 |
| 84 | Respiratory difficulties (HP:0002880) | 1.79465462 |
| 85 | Hypothermia (HP:0002045) | 1.77630816 |
| 86 | Microvesicular hepatic steatosis (HP:0001414) | 1.75157430 |
| 87 | Keratoconjunctivitis (HP:0001096) | 1.75069359 |
| 88 | Progressive inability to walk (HP:0002505) | 1.74470492 |
| 89 | Pallor (HP:0000980) | 1.74199031 |
| 90 | Neutropenia (HP:0001875) | 1.73611406 |
| 91 | Chronic sinusitis (HP:0011109) | 1.71750408 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69244619 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 1.69244619 |
| 94 | Hyperalaninemia (HP:0003348) | 1.69244619 |
| 95 | Albinism (HP:0001022) | 1.69123868 |
| 96 | Abnormality of the renal cortex (HP:0011035) | 1.69030797 |
| 97 | Abnormality of the labia minora (HP:0012880) | 1.67459445 |
| 98 | Abnormality of the ileum (HP:0001549) | 1.66482248 |
| 99 | Meckel diverticulum (HP:0002245) | 1.66255142 |
| 100 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.65942396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 4.01541253 |
| 2 | BCKDK | 3.10874135 |
| 3 | MST4 | 2.74363686 |
| 4 | VRK2 | 2.70807699 |
| 5 | VRK1 | 2.61363600 |
| 6 | STK16 | 2.52454711 |
| 7 | TESK2 | 2.40867961 |
| 8 | NUAK1 | 2.39566413 |
| 9 | ADRBK2 | 2.31927822 |
| 10 | TXK | 2.30876355 |
| 11 | TRIM28 | 2.26256748 |
| 12 | ZAK | 2.22218182 |
| 13 | TAOK3 | 2.08024432 |
| 14 | FRK | 2.02638702 |
| 15 | BUB1 | 2.01634700 |
| 16 | EIF2AK3 | 1.99906567 |
| 17 | PDK2 | 1.98884425 |
| 18 | EIF2AK1 | 1.83439424 |
| 19 | MAP4K1 | 1.64248052 |
| 20 | KDR | 1.60881591 |
| 21 | NME1 | 1.58484897 |
| 22 | WNK3 | 1.50949871 |
| 23 | IKBKE | 1.49880223 |
| 24 | PINK1 | 1.45914348 |
| 25 | GRK1 | 1.44321678 |
| 26 | SRPK1 | 1.41025104 |
| 27 | KIT | 1.33396562 |
| 28 | GRK6 | 1.26224385 |
| 29 | MAPK13 | 1.22309499 |
| 30 | RPS6KA4 | 1.20810141 |
| 31 | TLK1 | 1.18738501 |
| 32 | BMPR1B | 1.16078692 |
| 33 | DYRK2 | 1.11185211 |
| 34 | TEC | 1.10593555 |
| 35 | MUSK | 1.09207691 |
| 36 | IKBKB | 1.05547007 |
| 37 | PASK | 1.03102353 |
| 38 | PLK3 | 1.01891435 |
| 39 | GRK7 | 0.98697386 |
| 40 | PIK3CG | 0.97679458 |
| 41 | RPS6KA5 | 0.96353428 |
| 42 | SYK | 0.94093970 |
| 43 | ITK | 0.89992858 |
| 44 | PRKCQ | 0.89636787 |
| 45 | LYN | 0.89457030 |
| 46 | FES | 0.88635174 |
| 47 | PBK | 0.87033126 |
| 48 | INSRR | 0.86955388 |
| 49 | BTK | 0.83275104 |
| 50 | MAP2K6 | 0.82313073 |
| 51 | TBK1 | 0.82157702 |
| 52 | DYRK3 | 0.74257449 |
| 53 | MAPKAPK3 | 0.72209697 |
| 54 | MAP3K4 | 0.72074030 |
| 55 | CSNK1G3 | 0.71946277 |
| 56 | TSSK6 | 0.71562370 |
| 57 | CSF1R | 0.69876509 |
| 58 | IRAK4 | 0.69498266 |
| 59 | CDK8 | 0.69162801 |
| 60 | MARK3 | 0.66139484 |
| 61 | ATR | 0.63971839 |
| 62 | CDK3 | 0.63883927 |
| 63 | PLK1 | 0.63637670 |
| 64 | DAPK1 | 0.61349441 |
| 65 | OXSR1 | 0.58554802 |
| 66 | LCK | 0.58411446 |
| 67 | TYK2 | 0.58084286 |
| 68 | PRKCG | 0.57956020 |
| 69 | EIF2AK2 | 0.56614091 |
| 70 | CCNB1 | 0.56411743 |
| 71 | STK10 | 0.55324868 |
| 72 | ADRBK1 | 0.55169440 |
| 73 | CSNK1G2 | 0.52879812 |
| 74 | PIM1 | 0.52747444 |
| 75 | CSNK2A1 | 0.49836889 |
| 76 | MAP2K7 | 0.49722067 |
| 77 | CSNK2A2 | 0.49130569 |
| 78 | PRKCE | 0.46318668 |
| 79 | WEE1 | 0.45501588 |
| 80 | BRSK2 | 0.45060873 |
| 81 | NME2 | 0.42669048 |
| 82 | IRAK1 | 0.42333103 |
| 83 | CDK19 | 0.41445864 |
| 84 | CSNK1G1 | 0.41353816 |
| 85 | AURKB | 0.38811097 |
| 86 | JAK3 | 0.37820194 |
| 87 | MATK | 0.37375702 |
| 88 | NTRK3 | 0.35538378 |
| 89 | TESK1 | 0.34524750 |
| 90 | CDC7 | 0.34449877 |
| 91 | IGF1R | 0.33633371 |
| 92 | PIM2 | 0.33327318 |
| 93 | ATM | 0.33255584 |
| 94 | CSNK1A1L | 0.33038284 |
| 95 | MAP3K5 | 0.32254942 |
| 96 | PKN1 | 0.32158216 |
| 97 | PLK4 | 0.31910340 |
| 98 | AURKA | 0.31893557 |
| 99 | CHEK2 | 0.31318465 |
| 100 | PLK2 | 0.30689368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.29795359 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.44908946 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.08278233 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.03816840 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55297928 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.53446122 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.42264528 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.24332344 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92855375 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.91482791 |
| 11 | Basal transcription factors_Homo sapiens_hsa03022 | 1.86795531 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76490196 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.72470762 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69614366 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.69609362 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.68710501 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.67880444 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66478580 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66424129 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.65612349 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64356587 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.59359946 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54911956 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52639971 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51732159 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.51471081 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49595139 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42192105 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40271627 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.37926762 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.35715199 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.35082994 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34776804 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34327987 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.32640885 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.29982242 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28866514 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25043888 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23518819 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.20307800 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15230496 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14786609 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12541943 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.06609519 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.05571243 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03219984 |
| 47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03059979 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02543473 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00072084 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93062993 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92434913 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91293141 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90261110 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.89757857 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88203043 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86543227 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86022260 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81044882 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80917933 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77927510 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77091934 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74460463 |
| 63 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71988759 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71393161 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71016221 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70052627 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65820704 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62802977 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61022473 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60030949 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59961925 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58852406 |
| 73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57853505 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57261809 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53993191 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53895844 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51520187 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51504213 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49553457 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47404114 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44366862 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44025154 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43289256 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42825810 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.42823021 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.42618623 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42225161 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41776657 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41580869 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41234605 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40944539 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40058264 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39562150 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36563842 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.36388532 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34659772 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33766680 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33632683 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30441317 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27175260 |

